Regenerative medicine holds significant promise to pro-logical protection to the enclosed cells, recent studies have investigated the use of scaffolds beyond passive vide an alternative or complementary treatment for the millions of people affected annually by tissue and organ support by utilizing the chemical and physical properties of the material to retain cellular phenotype, improve cell loss from accidents, birth defects, and diseases. Tissue engineering, the combination of cells within biomateri-function, and/or impart macroscale tissue morphogenesis. One of the more recent focuses of scaffold develop-als, is primarily concerned with the ex vivo creation of long-lasting, viable tissues and cells in large yield. ment has been on mimicking or recapitulating the natural cell-to-cell and cell-to-matrix interactions that can be While promising advancements have been made in the design and development of engineered tissues, such as critical in maintaining cellular phenotype and viability. Decelluarization of native tissues and reseeding with cells liver, cartilage, bone, and blood vessels, some universal hurdles still hamper progress. The ability to precisely ex vivo has been one approach that has shown promising results. Extracellular matrices (ECM) from a variety of design materials that provide the appropriate chemical and mechanical support to the cells has proven to be a tissues have been used in the development of vascular grafts, heart valves, pericardium, subintestinal mucosa, formidable challenge. In addition, the inability to quickly vascularize cellular scaffolds following implantation urinary bladder, skin, and nerves (3, 6, 12) . Clinical applicability of these decellularized tissues, however, may be commonly results in the inefficient delivery of nutrients and cell necrosis. Recent publications, however, have limited due to the inability to fully characterize the matrix, variability in source, and pathogen transmission sought to address these issues.
concerns. An alternative, but similar, strategy is the use PROMISING SCAFFOLDS of fully characterized scaffolds that mimic native ECM. For example, Takezawa et al. used collagen vitrigel, a While the traditional roles of scaffolds in tissue design have been to provide mechanical and/or immuno-hydrogel, as a three-dimensional culturing system for the 242 NOLAN ET AL.
reconstruction of epithelial-mesenchyme, or hard connec-cell migration and controlled degradation rates (14, 15) . This approach allows for the design of materials that tive tissue (16). By vitrifying and rehydrating the hydrogel to create the vitrigel scaffold, anchorage-dependent have rates of degradation that match the rate of tissue regeneration. cells developed into organoids. Using this technology, they were able to reconstruct a three-dimensional intesti-ACCELERATING VASCULARIZATION nal epithelial-mesenchymal model, with additional experiments suggesting hard connective tissue formation.
Immediately following the implantation of an avascular scaffold, its reliance for oxygen and nutrient delivery Other materials have attempted to generate and retain cell-to-cell and cell-to-matrix interactions using novel on diffusion alone leads to lethal gradients within the implant. Nutrient-starved cells quickly lose function and cell culture systems that permit transition from the benchtop to the host. An example of such culture systems is initiate apoptotic pathways, which leads to poor performance and loss of cell viability. Therefore, there is a the use of thermoresponsive membranes, which hold varying adherent properties at different temperatures.
tremendous need for research strategies that will accelerate vascularization around or within the engineered tissue. Following assembly and growth within these artificial cell layers in vitro, the membranes can be thermally de-One approach to induce vascular in-growth has been the combination of porous scaffolds that are conducive tached from the culture place and the sheet may then be directly transplanted onto the damaged native tissue.
to vascular infiltration and sustained angiogenic growth factor delivery to induce neovascularization. Work by Tanaka et al. used these membranes for the culture of hepatocytes, which have been shown to benefit from Cho et al. illustrates this approach in engineering adipose tissue by utilizing poly(glycolic acid) (PGA) non-cell-to-cell and cell-to-matrix interactions (17). These membranes were found to not interfere with cell surface woven meshes supported with PGA fiber-based matrices and poly(L-lactic acid) (PLLA) to fabricate void pockets proteins and had the expected advantages of increased stability of function and reduced cellular apoptosis fol-and a mechanically stable environment for vascular growth (2) . The addition of basic fibroblast growth fac-lowing manipulation compared to controls. Another novel culture system used to allow cells to fabricate their tor (bFGF) to the matrix further accelerated neovascularization and adipogenesis. Another elegant approach own cell-to-matrix and cell-to-cell interactions has been the cell pellet culture system described in Akiyama et has been the work by Ehrbar et al., where vascular endothelial growth factor (VEGF) variants were coupled to a al. (1) . In this study, they evaluated the ability of the periosteal cell pellet culture system to engineer bone.
fibrin matrix (4) . The VEGF could then, in turn, be released via bulk matrix degradation or cell-demanded re-Using this system, the cells were able to fabricate their own ECM and cell-to-matrix interactions in vitro, as evi-lease. The tethering of VEGF within the material was found to have resulted in localized, controlled vascular denced by the presence of collagen fibers and adherent cells. Implantation in mice showed new bone formation networks without the hyperpermeability common with burst VEGF release. This concept illustrates that the and growth with osteoblasts, vascular canal invasion, and areas of calcification. Similar to intramembraneous combination of appropriate matrix selection and angiogenic growth factors can significantly improve tissue en-ossification, the present pellet system appears reliable and might be of assistance in solving some of the prob-graftment. Another approach is to use "helper" cells embedded lems associated with postimplantation bone resorption.
Recently, the use of tailored biomaterials with novel in the scaffold to promote angiogenesis. Specifically, the incorporation of human bone marrow-derived mesen-and unique properties, such as electrical conductivity, signaling capabilities, and cell-mediated degradation chymal stem cells (hMSCs) within scaffolds has been shown to improve vascular in-growth and engraftment. rates, have shown promise in actively promoting the function and engraftment of the engineered tissue. For For example, Ghajar et al. found significant improvements in vascular infiltration via early matrix metallo-example, Harrison et al. have investigated the unique properties of carbon nanotubes, such as electrical con-proteinase upregulation when hMSCs were embedded within fibrin matrices (5). In addition, hMSCs have been ductivity, to impact the microenvironment and direct cell growth (7). In addition, this material could prove used extensively in engineering soft tissues, where they have shown improved vascularization and engraftment. useful for cell tracking, microenvironment sensing, and as vectors for transfection agents. While cytotoxic ef-For example, Markowicz et al. found increased vessel in-growth and superior engraftment when human bone fects have been noted, this characteristic has been shown to be markedly reduced following chemical modification marrow-derived mesenchymal stem cells (hMSCs) were incorporated into collagen sponges (10). Other studies of the material. Furthermore, Rizzi and Hubbell applied protein engineering to fabricate cell-mediated degrada-found that the use of hMSCs lead to accelerated neovascularization in tissue models for myocardium, bone de-tion sites within custom-designed polymers to facilitate COMMENTARY 243 5. Ghajar, C. M.; Blevins, K. S.; Hughes, C. C.; George, fects, and nerve regeneration (8, 9, 13) . Other cell types S. C.; Putnam, A. J. Mesenchymal stem cells enhance anhave also been shown to improve vascular infiltration, giogenesis in mechanically viable prevascularized tissues such as the human vascular endothelial cells used by via early matrix metalloproteinase upregulation. Tissue Miki et al. (11) . In this study, increased vascularization Eng. 12(10):2875 Eng. 12(10): -2888 2006. 6 rial, cell loading, and spatial parameters of the final tis-
